Research Program Licenses. Subject to the rights retained by Ambrx in Section 3.1.1(c) and the terms and conditions of this Agreement, Ambrx hereby grants to Agensys an exclusive license (even as to Ambrx) to carry out the activities in the Research Program during the Research Term in the Territory in the Field under Ambrx Patent Rights, with the right to sublicense as set forth in Section 3.4.1.
Appears in 3 contracts
Sources: Research Collaboration and Exclusive License Agreement (Ambrx Biopharma Inc.), Research Collaboration and Exclusive License Agreement (Ambrx Biopharma Inc.), Research Collaboration and Exclusive License Agreement (Ambrx Inc)